<unk>  is an immnunologic adjuvant that is FDA approved for the treatment of actinic keratosis, external genital warts.   Common adverse reactions include erythema, edema, erosion/ulceration, exudate, scabbing/crusting, headache, application site pain, application site irritation, application site pruritus, fatigue, influenza-like illness, and nausea.
Imiquimod
Clobetasol propionate
Clobetasol
Tretinoin 
Halobetasol
Isotretinoin
Alitretinoin
Cryosurgery